Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

American Heart Journal

Volumn 160, Issue 5, 2010, Pages 928-933

  Wu, Audrey H ^a   Ghali, Jalal K ^b   Neuberg, Gerald W ^c   O'Connor, Christopher M ^d   Carson, Peter E ^e   Levy, Wayne C ^f  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b DETROIT MEDICAL CENTER   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMLODIPINE; DIURETIC AGENT; FUROSEMIDE; METOLAZONE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL INDICATOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC HEART FAILURE; URIC ACID BLOOD LEVEL;

AGED; ALLOPURINOL; BIOLOGICAL MARKERS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; UNITED STATES; URIC ACID;

EID: 78649380645     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.006     Document Type: Article

References (27)

1. Chen J.H., Chuang S.Y., and Chen H.J. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study Arthritis Rheum 61 2009 225 232
2. Wannamethee S.G., Shaper A.G., and Whincup P.H. Serum urate and the risk of major coronary heart disease events Heart 78 1997 147 153
3. Anker S.D., Doehner W., and Rauchhaus M. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
4. Alimonda A.L., Nunez J., and Nunez E. Hyperuricemia in acute heart failure. More than a simple spectator? Eur J Intern Med 20 2009 74 79
5. Farquharson C.A., Butler R., and Hill A. Allopurinol improves endothelial dysfunction in chronic heart failure Circulation 106 2002 221 226
6. Doehner W., Schoene N., and Rauchhaus M. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2002 2619 2624
7. Hare J.M., Mangal B., and Brown J. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309
8. Packer M., O'Connor C.M., and Ghali J.K. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med 335 1996 1107 1114
9. Levy W.C., Mozaffarian D., and Linker D.T. The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
10. Eshaghian S., Horwich T.B., and Fonarow G.C. Relation of loop diuretic dose to mortality in advanced heart failure Am J Cardiol 97 2006 1759 1764
11. Neuberg G.W., Miller A.B., and O'Connor C.M. Diuretic resistance predicts mortality in patients with advanced heart failure Am Heart J 144 2002 31 38
12. Aaronson K.D., Schwartz J.S., and Chen T.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
13. Oreopoulos A., Padwal R., and Kalantar-Zadeh K. Body mass index and mortality in heart failure: a meta-analysis Am Heart J 156 2008 13 22
14. Matthews J.C., Koelling T.M., and Pagani F.D. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
15. Allen L.A., Felker G.M., and Pocock S. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Eur J Heart Fail 11 2009 170 177
16. Kamath S.A., Drazner M.H., and Wynne J. Characteristics and outcomes in African American patients with decompensated heart failure Arch Intern Med 168 2008 1152 1158
17. Vuorinen-Markkola H., and Yki-Jarvinen H. Hyperuricemia and insulin resistance J Clin Endocrinol Metab 78 1994 25 29
18. Facchini F., Chen Y.D., and Hollenbeck C.B. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration Jama 266 1991 3008 3011
19. Leyva F., Anker S., and Swan J.W. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure Eur Heart J 18 1997 858 865 (Pubitemid 27208159)
20. Hayashi K., Kimata H., and Obata K. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters J Card Fail 14 2008 238 244
21. Cingolani H.E., Plastino J.A., and Escudero E.M. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study J Card Fail 12 2006 491 498
22. George J., and Struthers A. The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) trial: a question of dose J Am Coll Cardiol 53 2009 2405
23. George J., Carr E., and Davies J. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 2006 2508 2516
24. Ogino K., Kato M., and Furuse Y. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study Circ Heart Fail 3 2010 73 81
25. Packer M., Fowler M.B., and Roecker E.B. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199
26. Culleton B.F., Larson M.G., and Kannel W.B. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study Ann Intern Med 131 1999 7 13
27. Rathmann W., Funkhouser E., and Dyer A.R. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults Ann Epidemiol 8 1998 250 261